12/4
08:22 am
imab
I-Mab Leads Our Spotlight On 3 US Penny Stocks [Yahoo! Finance]
Medium
Report
I-Mab Leads Our Spotlight On 3 US Penny Stocks [Yahoo! Finance]
11/21
07:00 am
imab
I-Mab to Participate at the Piper Sandler Healthcare Conference
Low
Report
I-Mab to Participate at the Piper Sandler Healthcare Conference
11/15
08:04 am
imab
I-Mab (NASDAQ: IMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Low
Report
I-Mab (NASDAQ: IMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
11/14
07:09 am
imab
I-Mab Reports Third Quarter 2024 Results [Yahoo! Finance]
Low
Report
I-Mab Reports Third Quarter 2024 Results [Yahoo! Finance]
11/14
07:00 am
imab
I-Mab Reports Third Quarter 2024 Results
Low
Report
I-Mab Reports Third Quarter 2024 Results
11/6
07:00 am
imab
I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer
Medium
Report
I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer
10/31
07:00 am
imab
I-Mab to Release Q3 2024 Financial Results on November 14, 2024
Medium
Report
I-Mab to Release Q3 2024 Financial Results on November 14, 2024
10/30
07:00 am
imab
I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024
Medium
Report
I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024
10/28
07:00 am
imab
I-Mab to Participate at the Truist Securities BioPharma Symposium
Low
Report
I-Mab to Participate at the Truist Securities BioPharma Symposium